Table 3 Correlation analysis between PAK1 expression and clinicopathological characteristics in 72 patients with primary pancreatic cancer
Characteristics | PAK1 | P-value | ||
|---|---|---|---|---|
| Â | Low/none No. cases (%) | High No. cases (%) | ||
Gender | Male | 18 (45.0% ) | 22(55.0%) | 0.673 |
| Â | Female | 16(50.0%) | 16(50.0%) | Â |
Age (years) | ≤ 60 | 15(36.6%) | 26(63.4%) | 0.038 |
| Â | > 60 | 19(61.3%) | 12(38.7%) | Â |
Pathologic differentiation | Poor | 25(61.0%) | 16(39.0%) | 0.007 |
| Â | Moderate/Well | 9(29.0%) | 22(71%) | Â |
Clinical stage | I-III | 29(50.0% ) | 29(50.0%) | 0.706 |
| Â | IV | 5(35.7%) | 9(64.3%) | Â |
T classification | T1 + T2 | 4(33.3%) | 8(66.7%) | 0.291 |
|  | T3 + T4 | 30(50.0%) | 30(50.0%) |  |
N classification | No | 20 (44.4%) | 25(55.6%) | 0.542 |
| Â | Yes | 14 (51.9%) | 13 (48.1%) | Â |
M classification | M0 | 29 (50.0%) | 29 (50.0%) | 0.337 |
| Â | M1 | 5 (35.7%) | 9 (64.3%) | Â |